Our study adds to this body of knowledge by confirming the high expression of CEP55 in approximately 80% of BC patients and in MDA-MB-231 and MCF-7 BC cell lines, consistent with previous work [13, 23]. The gene discussed is CEP55; the disease is breast cancer.